XTALPI (02228) announced that it has successfully delivered an automated workstation for formulation stability testing to the global chemical giant BASF. This deployment assists BASF in establishing a fully automated system covering the entire workflow from sample management and testing analysis to data management. Chemistry is fundamental to material transformations and permeates every aspect of the modern industrial system. BASF is a global leader in the chemical industry, with operations spanning chemicals, materials, industrial solutions, and nutrition and care. This collaboration represents another significant advancement for the group's intelligent autonomous laboratory solutions within the chemical automation sector, demonstrating that its technical capabilities and commercial delivery prowess have once again been validated by a leading industry enterprise. Leveraging its international leadership in large-scale robotic laboratories, exceptional customization capabilities, and cross-domain adaptability, the group continues to help accumulate high-precision R&D data in fields such as pharmaceutical research, petrochemicals, new energy, and new materials, providing next-generation infrastructure for industry digitalization and intelligent upgrading. The successful implementation of this project was facilitated by the deep integration of the group's unique modular standard platform for intelligent autonomous laboratories with its agile customization capabilities. This platform has already achieved successful deployments in multiple high-value sectors, including new drug development, chemical synthesis, and new material discovery, accumulating substantial experience. Its modular design ensures efficient deployment and stable operation while laying the foundation for rapid delivery. In this collaboration, the group successfully passed rigorous verification against top global technical standards and achieved a near "zero-defect" delivery outcome. This not only validates the advanced nature of its robotic automation experimental technology and the maturity of its solutions but also serves as strong proof of its commercial capabilities, further solidifying the group's authoritative position in the field of chemical automation. The group's autonomous laboratories not only achieve a high degree of standardization in experimental operations and a significant increase in experimental throughput but also function as a platform for efficiently generating high-precision, structured data. They continuously and stably collect vast amounts of standardized experimental data, providing crucial fuel for the development and continuous optimization of proprietary AI models in R&D fields. As AI penetrates more deeply into R&D, intelligent laboratories capable of automated execution and scalable generation of high-quality data have become core infrastructure for future AI-driven research. The group has established a first-mover and leading advantage in this area, building a unique competitive barrier. As a globally scarce platform that deeply integrates AI algorithms with large-scale robotic experimentation, the group's automated laboratories continue to be selected and endorsed by top-tier clients, driving continuous technological upgrades and experience accumulation, resulting in step-by-step improvements in delivery capability. Currently, the group's automated experimental solutions serve numerous large enterprises and top research institutions across different fields, including international pharmaceutical companies, Sinopec, Fudan University, Singapore's Agency for Science, Technology and Research (A*STAR), and the Hengqin Laboratory. Through its business model of "standardized platform + agile customization," its business scope is rapidly expanding and scaling from pharmaceutical R&D into multi-trillion-dollar markets like major chemicals and new energy, continually opening up new growth avenues. Looking ahead, the group will continue to deepen strategic synergies with global industry leaders. Through close collaboration with clients, it will accelerate the technological iteration and experience accumulation of its intelligent laboratories, providing core infrastructure for revolutionizing industrial R&D efficiency and ushering chemistry research into a new era driven by AI and robotics.